ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,647Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 457

$715K Total Retail Price of All Prescriptions

Rank: 79 out of 457

600 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 15,873 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 1,053 940 1 1
SIMVASTATIN 900 806 2 2
LISINOPRIL 838 740 3 3
METFORMIN HCL 644 568 4 6
LEVOTHYROXINE SODIUM 509 436 5 5
VIAGRA 432 425 6 63
RANITIDINE HCL 404 361 7 17
AMLODIPINE BESYLATE 397 358 8 4
VOLTAREN 381 349 9 34
METOPROLOL TARTRATE 365 321 10 7
VITAMIN D2 342 323 11 76
ATENOLOL 318 277 12 11
ALENDRONATE SODIUM 302 280 13 16
HYDROCHLOROTHIAZIDE 300 287 14 8
CIALIS 267 245 15 119
TAMSULOSIN HCL 262 261 16 36
CRESTOR 260 228 17 9
CLOPIDOGREL 253 233 18 19
LANSOPRAZOLE 223 206 19 74
MECLIZINE HCL 211 206 20 55
PLAVIX 207 200 21 24
GLIPIZIDE 202 185 22 42
IBUPROFEN 189 142 23 14
DICLOFENAC SODIUM 157 139 24 49
LIVALO 153 128 25 296
ENALAPRIL MALEATE 152 152 26 35
LOVASTATIN 152 152 26 25
PANTOPRAZOLE SODIUM 148 134 28 59
DONEPEZIL HCL 147 142 29 22
CARVEDILOL 144 123 30 20
POTASSIUM CHLORIDE 141 113 31 28
DIOVAN 139 134 32 30
AZITHROMYCIN 136 120 33 44
GLYBURIDE 136 120 R 33 64
ADVAIR DISKUS 135 119 35 27
FUROSEMIDE 134 101 36 10
GABAPENTIN 132 115 37 15
VENTOLIN HFA 130 111 38 96
NEXIUM 124 96 39 12
CLOTRIMAZOLE-BETAMETHASONE 116 96 40 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 99 41 37
BENICAR 110 110 42 90
FENOFIBRATE 110 93 42 46
DOXAZOSIN MESYLATE 107 102 44 73
SINGULAIR 105 101 45 43
ACTONEL 103 103 46 117
PENTOXIFYLLINE 101 95 47 67
LACTULOSE 100 94 48 78
MELOXICAM 98 73 49 41
TRIAMCINOLONE ACETONIDE 97 94 50 132
KETOCONAZOLE 92 84 51 92
METOPROLOL SUCCINATE 91 85 52 21
WARFARIN SODIUM 89 80 53 38
BENICAR HCT 88 87 54 111
DIOVAN HCT 88 79 54 51
GLYBURIDE-METFORMIN HCL 85 83 R 56 70
LOSARTAN POTASSIUM 83 76 57 18
AMLODIPINE BESYLATE-BENAZEPRIL 82 77 58 72
TRADJENTA 76 71 59 412
CILOSTAZOL 73 73 60 88
CLONIDINE HCL 73 41 60 52
CLOBETASOL PROPIONATE 73 64 60 125
FLUTICASONE PROPIONATE 72 61 63 40
INSULIN SYRINGE 72 58 63 79
CIPROFLOXACIN HCL 70 56 65 71
MONTELUKAST SODIUM 69 62 66 86
NAPROXEN 67 52 67 65
AVODART 63 47 68 110
LEVEMIR 63 45 68 225
VESICARE 60 54 70 173
TEMAZEPAM 59 56 71 48
DIGOXIN 56 53 72 69
FOLIC ACID 55 53 73 81
FINASTERIDE 55 55 73 85
IBANDRONATE SODIUM 54 54 75 183
SPIRIVA 52 52 76 101
LANTUS 51 43 77 56
AMMONIUM LACTATE 51 51 77 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.